Tag: Recurrent Clostridioides difficile infection

Microbiome Therapeutics After Recurrent C. diff: What’s Real, What’s Hype, and What’s Next?

by Nancy Ogbonna - 03

Microbiome Therapeutics After Recurrent C. diff What’s Real, What’s Hype, and What’s Next Review Abstract Recurrent Clostridioides difficile infection (rCDI) remains a significant and persistent challenge in clinical practice, occurring in approximately 20 to 30 percent of patients after an initial episode. The risk of recurrence increases with

Microbiome Therapeutics After Recurrent C. diff: What’s Real, What’s Hype, and What’s Next?